Back to RXRX
Plancorp, LLC RXRX Position History
Recursion Pharmaceuticals, Inc.
Quarters held
4
Latest value
$270K
Q3 2026
Peak value
$346K
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $346K |
| Q1 2026 | $277K |
| Q2 2026 | $229K |
| Q3 2026 | $270K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $270K | 67.0K | — | — |
| Q2 2026 | $229K | 69.5K | — | — |
| Q1 2026 | $277K | 84.5K | — | — |
| Q4 2025 | $346K | 84.5K | — | — |